InflaRx N.V. (IFRX) Financials

IFRX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 133.0 million 19.5 million
2023-09-30 137.1 million 12.2 million
2023-06-30 144.6 million 9.0 million
2023-03-31 94.1 million 8.4 million

IFRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -11.4 million 500769
2023-09-30 -5.6 million 764440
2023-06-30 -12.2 million 1.1 million
2023-03-31 -11.5 million 1.3 million

IFRX Net Income

No data available :(

IFRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 99.9 million - 1.2 million
2023-09-30 121.4 million - 1.2 million
2023-06-30 111.2 million - 1.3 million
2023-03-31 74.5 million - 1.4 million

IFRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 65.1 million
2023-09-30 62.3 million
2023-06-30 62.0 million
2023-03-31 48.8 million

IFRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 9316 8.7 million 4.6 million 74305
2023-09-30 22516 7.7 million 3.1 million 1.7 million
2023-06-30 20253 11.9 million 3.9 million 300159
2023-03-31 6590 16.1 million 3.9 million -

IFRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2461 371501
2023-09-30 64368 270077
2023-06-30 - 157705
2023-03-31 - -

IFRX

Price: $1.43

52 week price:
1.14
5.20

Earnings Per Share: -0.84 USD

P/E Ratio: -2.19

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 38219

Market Capitalization: 84.2 million

Links: